{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:41:52Z","timestamp":1788327712753,"version":"build-2803163510"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosdigitalhealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Digit Health"],"abstract":"<jats:p>Age-related Macular Degeneration (AMD) is a major cause of irreversible vision loss in individuals over 55 years old in the United States. One of the late-stage manifestations of AMD, and a major cause of vision loss, is the development of exudative macular neovascularization (MNV). Optical Coherence Tomography (OCT) is the gold standard to identify fluid at different levels within the retina. The presence of fluid is considered the hallmark to define the presence of disease activity. Anti-vascular growth factor (anti-VEGF) injections can be used to treat exudative MNV. However, given the limitations of anti-VEGF treatment, as burdensome need for frequent visits and repeated injections to sustain efficacy, limited durability of the treatment, poor or no response, there is a great interest in detecting early biomarkers associated with a higher risk for AMD progression to exudative forms in order to optimize the design of early intervention clinical trials. The annotation of structural biomarkers on optical coherence tomography (OCT) B-scans is a laborious, complex and time-consuming process, and discrepancies between human graders can introduce variability into this assessment. To address this issue, a deep-learning model (SLIVER-net) was proposed, which could identify AMD biomarkers on structural OCT volumes with high precision and without human supervision. However, the validation was performed on a small dataset, and the true predictive power of these detected biomarkers in the context of a large cohort has not been evaluated. In this retrospective cohort study, we perform the largest-scale validation of these biomarkers to date. We also assess how these features combined with other EHR data (demographics, comorbidities, etc) affect and\/or improve the prediction performance relative to known factors. Our hypothesis is that these biomarkers can be identified by a machine learning algorithm without human supervision, in a way that they preserve their predictive nature. The way we test this hypothesis is by building several machine learning models utilizing these machine-read biomarkers and assessing their added predictive power. We found that not only can we show that the machine-read OCT B-scan biomarkers are predictive of AMD progression, we also observe that our proposed combined OCT and EHR data-based algorithm outperforms the state-of-the-art solution in clinically relevant metrics and provides actionable information which has the potential to improve patient care. In addition, it provides a framework for automated large-scale processing of OCT volumes, making it possible to analyze vast archives without human supervision.<\/jats:p>","DOI":"10.1371\/journal.pdig.0000106","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T13:31:54Z","timestamp":1676467914000},"page":"e0000106","update-policy":"https:\/\/doi.org\/10.1371\/journal.pdig.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Automated large-scale prediction of exudative AMD progression using machine-read OCT biomarkers"],"prefix":"10.1371","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4346-8239","authenticated-orcid":true,"given":"Akos","family":"Rudas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Corradetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Rakocz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1984-2139","authenticated-orcid":true,"given":"Oren","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-3306","authenticated-orcid":true,"given":"Srinivas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"issue":"2","key":"pdig.0000106.ref001","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"WL Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"6","key":"pdig.0000106.ref002","first-page":"493","article-title":"Updates on the Epidemiology of Age-Related Macular Degeneration","volume":"6","author":"JB Jonas","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"pdig.0000106.ref003","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"FL Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"pdig.0000106.ref004","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group","volume":"127","author":"RF Spaide","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"pdig.0000106.ref005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3","volume":"125","author":"SR Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"pdig.0000106.ref006","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/s41433-020-0764-9","article-title":"Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration","volume":"34","author":"S Chandra","year":"2020","journal-title":"Eye (Lond)."},{"issue":"3","key":"pdig.0000106.ref007","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"E Daniel","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"pdig.0000106.ref008","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/s41433-021-01487-0","article-title":"Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations","volume":"35","author":"L Kodjikian","year":"2021","journal-title":"Eye (Lond)."},{"key":"pdig.0000106.ref009","doi-asserted-by":"crossref","first-page":"5308597","DOI":"10.1155\/2020\/5308597","article-title":"Effect of the Duration of Intraretinal or Subretinal Fluid on the Response to Treatment in Undertreated Age-Related Macular Degeneration","volume":"2020","author":"I Yoshida","year":"2020","journal-title":"J Ophthalmol."},{"key":"pdig.0000106.ref010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/OPTH.S106734","article-title":"Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration","volume":"10","author":"N Dervenis","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"pdig.0000106.ref011","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00417-017-3693-y","article-title":"Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration","volume":"255","author":"J Lei","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"pdig.0000106.ref012","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcjo.2021.01.005","article-title":"Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration","volume":"56","author":"G Corradetti","year":"2021","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"pdig.0000106.ref013","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.ophtha.2019.05.016","article-title":"OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study","volume":"126","author":"M Nassisi","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"pdig.0000106.ref014","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41746-021-00411-w","article-title":"Automated identification of clinical features from sparsely annotated 3-dimensional medical imaging","volume":"4","author":"N Rakocz","year":"2021","journal-title":"NPJ Digit Med"},{"issue":"1","key":"pdig.0000106.ref015","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1038\/s41598-022-06273-w","article-title":"A multimodal deep learning system to distinguish late stages of AMD and to compare expert vs. AI ocular biomarkers","volume":"12","author":"KA Thakoor","year":"2022","journal-title":"Sci Rep"},{"issue":"15","key":"pdig.0000106.ref016","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1002\/sim.8981","article-title":"Developing more generalizable prediction models from pooled studies and large clustered data sets","volume":"40","author":"VMT de Jong","year":"2021","journal-title":"Stat Med."},{"issue":"9","key":"pdig.0000106.ref017","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"J De Fauw","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"pdig.0000106.ref018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2013.08.011","article-title":"Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies","volume":"121","author":"U Schmidt-Erfurth","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"pdig.0000106.ref019","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1167\/iovs.18-24143","article-title":"Quantity of Intraretinal Hyperreflective Foci in Patients With Intermediate Age-Related Macular Degeneration Correlates With 1-Year Progression","volume":"59","author":"M Nassisi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"pdig.0000106.ref020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00417-021-05419-2","article-title":"Optical coherence tomography predictors of progression of non-exudative age-related macular degeneration to advanced atrophic and exudative disease","volume":"260","author":"S Amarasekera","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"pdig.0000106.ref021","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41591-020-0867-7","article-title":"Predicting conversion to wet age-related macular degeneration using deep learning","volume":"26","author":"J Yim","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"pdig.0000106.ref022","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/ICU.0000000000000756","article-title":"Current status of home monitoring technology for age-related macular degeneration","volume":"32","author":"MA Busquets","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"pdig.0000106.ref023","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/jcm10071355","article-title":"Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration","volume":"10","author":"AC Ho","year":"2021","journal-title":"J Clin Med."},{"issue":"5","key":"pdig.0000106.ref024","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaophthalmol.2017.0133","article-title":"Determining the Value of Home Monitoring of Patients With Age-Related Macular Degeneration","volume":"135","author":"S Pershing","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"pdig.0000106.ref025","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.3390\/ijms19113688","article-title":"The Question of a Role for Statins in Age-Related Macular Degeneration","volume":"19","author":"M Roizenblatt","year":"2018","journal-title":"Int J Mol Sci."},{"key":"pdig.0000106.ref026","volume-title":"Chronic Conditions Data Warehouse [Internet]","year":"2021"},{"issue":"5","key":"pdig.0000106.ref027","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cell.2018.02.010","article-title":"Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning","volume":"172","author":"D Kermany","year":"2018","journal-title":"Cell"},{"issue":"8","key":"pdig.0000106.ref028","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/IAE.0000000000002210","article-title":"AMISH EYE STUDY: Baseline Spectral Domain Optical Coherence Tomography Characteristics of Age-Related Macular Degeneration","volume":"39","author":"MG Nittala","year":"2019","journal-title":"Retina"},{"key":"pdig.0000106.ref029","article-title":"Scikit-Learn: Machine Learning in Python","author":"F. Pedregosa","year":"2011","journal-title":"J Mach Learn Res."},{"issue":"61","key":"pdig.0000106.ref030","first-page":"10","article-title":"Statsmodels: Econometric and statistical modeling with python","volume":"57","author":"S Seabold","year":"2010","journal-title":"Proc. Python Sci. Conf"}],"container-title":["PLOS Digital Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pdig.0000106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T13:32:19Z","timestamp":1676467939000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pdig.0000106"}},"subtitle":[],"editor":[{"given":"Nan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pdig.0000106","relation":{},"ISSN":["2767-3170"],"issn-type":[{"value":"2767-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]}}}